Freenome said late Monday it closed its business combination with Perceptive Capital Solutions (PCSC), with the combined company expected to begin trading on Nasdaq under the "FRNM" ticker.
The combined company, to be renamed Freenome, is expected to have $310 million in gross proceeds, according to a statement.
Freenome will use the proceeds to advance its cancer detection tests, according to the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.